Daily Dose: Global Deaths from Ischemic Stroke May Reach 5 Million by 2030
Your daily dose of clinical news you may have missed.
Mental Health in Women with Obesity: An Expert Interview
A nationally recognized obesity expert discusses mental health in women with obesity.
Migraine without Aura May Increase Stroke Risk for Women Taking Combined Hormonal Contraceptives
The findings contradict published clinical guidelines that warn against use of estrogen-containing birth control by women who have migraine with aura.
Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Trial
Findings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.
GSK Adult RSV Vaxx: Public Health Expert Reviews Topics for ACIP Meeting in June
Immunize.org president and CEO Kelly Moore, MD, MHP, describes the holistic view the ACIP will take of the virus, the vaccine, and the overall economics of the immunization.
Daily Dose: Rise in Diabetes-Related Vascular Deaths Linked to Renal Complications
Statin Therapy May be Protective Against Stroke in People with Atrial Fibrillation: New Study
Statin therapy initiated within 1 year of diagnosis of atrial fibrillation reduced the risk of ischemic stroke or systemic embolism by nearly 20%.
Global Deaths from Ischemic Stroke May Reach 5 Million by 2030, According to New Study
Findings also showed that between 1990 and 2019, the global number of ischemic stroke deaths rose from 2 million to 3 million.
FDA Advisory Group Votes in Favor of Pfizer Investigational Maternal RSV Vaccine Candidate
The Pfizer vaccine RSVpreF administered to pregnant people was judged by the advisory committee to be effective at preventing RSV in infants from birth to 6 months.
First RSV Vaccine Brings "Sense of Relief" to Public Health Experts, Says Immunize.org President
Kelly Moore, MD, MPH, says the public health community is relieved by the FDA's approval and excited at "the chance to finally do something about the disease."
Daily Dose: Long-term Opioid Use Affects 1 in 5 with Musculoskeletal Pain
COPD Increases Risk for Heart Failure in People who Experience AMI
“Patients with COPD who have AMI are less aggressively treated than those without COPD," leading to higher in-hospital mortality and long-term mortality,” wrote authors.
WHO: Do Not Use Nonsugar Sweeteners for Weight Management or for Decreasing the Risk of Noncommunicable Diseases
In a new guideline, the WHO recommends against the use of nonsugar sweeteners to control body weight or reduce the risk of noncommunicable diseases.
First Opioid Rx Leads to Long-term Use in 1 of 5 with Rheumatic or Musculoskeletal Disorders
Patients with rheumatoid arthritis and fibromyalgia were at the greatest risk of transitioning to long-term opioid use 1 year after a first prescription, a new study found.
FDA Grants Dapagliflozin Label Expansion for Treatment of Full Spectrum of Heart Failure
The label expansion is based on findings from the pivotal phase 3 DELIVER trial in which dapagliflozin reduced the composite CV/HF endpoint in HF patients with HFmrEF or HFpEF.
Daily Dose: FDA Approves Fezolinetant for Treatment of Hot Flashes Caused by Menopause
Renal Complications Drive Increase in Deaths Related to Vascular Complications in Adults with Diabetes
AACE 2023. Deaths among persons with diabetes in the US related to vascular complications increased from 2001 to 2020, primarily driven by renal complications.
9 New Studies on Women's Health in Recognition of Women's Health Week 2023
Women's Health Week (May 14-20, 2023) is an ideal opportunity to review the top research, policy shifts, and potential drug approvals that affect your patient panel.
3 Things for Primary Care to Remember About Physical Medicine and Rehabilitation
Scott Laker, MD, vice president of the AAPM&R, offers 3 thoughts on what primary care clinicians should think of when they think about PM&R.
Daily Dose: Anxiety in America
